A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with this rare disease. GlycoNet investigators… Read More
XEN1101 Phase 3 epilepsy program continues to progress with X-TOLE2 and X-TOLE3 in focal onset seizures and X-ACKT in primary generalized tonic-clonic seizures; completion of patient enrollment in X-TOLE2 expected in… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An Act respecting pharmacare (Pharmacare Act), to incrementally implement a universal, single-payer pharmacare system… Read More
ROCKVILLE, MD & EDMONTON, AB – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that Canadian securities regulators have granted exemptive relief for the Company’s share repurchase program,… Read More
Major asset acquisition from a U.S.-based company marks another milestone for Canada’s largest biotechnology company VANCOUVER, BC – STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of… Read More
